Indee Labs Closes $2.6M in Seed Funding From Founders Fund’s FF Science and Main Sequence Ventures
Indee Labs is developing hardware for gene delivery using microfluidic vortex shedding (µVS). The team has already demonstrated revolutionary improvements over existing gene delivery methods including ...
Indee Labs to complete the development and launch of Hydropore RUO and Cell Therapy along with a direct DNA knock-in kit, enabled by BroadOak's strategic investment and domain expertise. BERKELEY, ...
LOS ANGELES, CA, UNITED STATES, August 3, 2026 /EINPresswire.com/ — Indee, the trusted secure screening platform serving premier studios, networks, guilds, and ...
As part of the collaboration, GenScript is providing a variety of single-strand and double-strand (ssDNA and dsDNA) constructs for direct DNA inserts, while the team at Indee Labs is optimizing the ...
BERKELEY, Calif., Jan. 5, 2021 /PRNewswire/ -- Indee Labs today announced the addition of three of the largest pharmaceutical companies, multiple biotechnology companies as well as Stanford's Cell ...
BERKELEY, Calif.--(BUSINESS WIRE)--Indee Labs is a biotechnology company developing the µVS Delivery System TM for non-viral intracellular or gene delivery. The team at Indee Labs was recently awarded ...
CXO(s) of Indee include Abhishek Raj (Chief Operating Officer), Sharan Reddy (CEO), Vivek Venugopalan (Chief Technology Officer). Functional leader(s) of Indee include Kunal Bachhawat A (Director - ...
Indee Labs received US$2.6M in venture financing extending its seed-stage funding to more than US$5.4M (AU$7.1M). This will accelerate the development of Indee Labs' gene therapy manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results